In fact, using a microfluidically supported biochip designed as dynamically perfused three-dimensional tumour model, we show that ChA treatment of M1, but not of M2, causes marked TNFα secretion and loss of viability of MFC-7 cells, an effect that could be reversed by selective TNFα neutralization using TNFα antibodies. This evidence concerns the gene TNF and neoplasm.